 |
By KATIE THOMAS
Published: December 3, 2012
They call it the patent cliff.
Brand-name drug makers have feared it for years. And now the makers of generic drugs fear it, too.
This year, more than 40 brand-name drugs — valued at $35 billion ...
Posted Tuesday, December 4th 2012 at 1:25AM
(more)
|